Intellia Therapeutics

Intellia Therapeutics

Intellia Therapeutics

Treating genetic disease at the cutting edge: Intellia Therapeutics is a CRISPR/Cas9 focused biotechnology company.
Founded
2014
Raised
$193M
Follow us
Alexa global traffic share
Twitter followers
05 May 2016
$108,000,000
IPO
01 Sep 2015
$70,000,000
Venture capital (Series B)
18 Nov 2014
$15,000,000
Venture capital (Series A)